RA Capital Management »

Biogen Idec shares owned by RA Capital Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by RA Capital Management

Quarter filed Position value Share count Share price at filing
2010-12-31 $7.1M 106k 67.05

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH
Climb Bio SH (ELYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Morgan Stanley
Goldman Sachs Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec